NDC 53489-355 - Labetalol Hydrochloride
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 53489-355
- Package NDCs from labels
- 53489-355-07, 53489-355-06, 53489-355-01, 53489-355-03, 53489-355-05, 53489-355-10
- Manufacturer
- Mutual Pharmaceutical Company, Inc.
- Effective date
- 2007-01-03
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LABETALOL HYDROCHLORIDE TABLETS, USP | Mutual Pharmaceutical Company, Inc. | 2007-01-03 | HUMAN PRESCRIPTION DRUG LABELING |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 53489-355-01 | Labetalol Hydrochloride | 100 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 100 | 1 | |
| 53489-355-03 | Labetalol Hydrochloride | 250 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 250 | 1 | |
| 53489-355-05 | Labetalol Hydrochloride | 500 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 500 | 1 | |
| 53489-355-06 | Labetalol Hydrochloride | 60 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 60 | 1 | |
| 53489-355-07 | Labetalol Hydrochloride | 30 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 30 | 1 | |
| 53489-355-10 | Labetalol Hydrochloride | 1000 in 1 BOTTLE, PLASTIC | TABLET, FILM COATED | 1000 | 1 |
DailyMed Dashboard NDC Coverage#
DailyMed Socrata Ingredients#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Advagen Pharma Ltd | 1c680447-b43a-4ff1-bc64-2c2174ca1c9a | 2026-04-02 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d4364caf-46c6-4144-9ba5-2c561e4f3a95 | 2026-03-26 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 3909ac9e-6818-4c5d-ad0e-52865a574b45 | 2026-03-25 | Warnings, Adverse reactions | 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 35e7bce0-d9ff-4f8b-95c5-218da2a2d929 | 2026-03-25 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | f7f7fade-98a6-4741-bfb9-f1eb54ad4565 | 2026-03-25 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | d207396a-068e-4229-88cc-a1a4df7aeff2 | 2026-03-07 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | A-S Medication Solutions | b4a5f170-a400-4986-8c64-f55d0413f0f6 | 2026-03-07 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Heritage Pharmaceuticals Inc. d/b/a Avet Pharmaceuticals Inc. | bf84ebae-3c91-4448-b1db-8e5ed3053866 | 2026-03-05 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Major Pharmaceuticals | 35b5fd32-581d-427b-9a13-b7a02846d21d | 2026-03-03 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Zydus Pharmaceuticals USA Inc. | 5942a5a8-c3c1-4ecb-921e-9bc92393bdf8 | 2026-03-02 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Unichem Pharmaceuticals (USA), Inc. | ed0188ba-3fd3-4680-a829-ba242a115fab | 2026-02-25 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Biocon Pharma Inc. | 27e4ab03-c17b-4268-912c-e45a5e8f8dd8 | 2026-02-19 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 0db22a64-1863-4188-850b-273ea746e327 | 2026-02-09 | Warnings, Adverse reactions | 896766 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | d8b69cc9-bdee-4e24-a3d8-d1887de5a17d | 2026-02-06 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Bryant Ranch Prepack | 6f919513-500e-4a05-935e-b6fc1615368a | 2026-01-29 | Warnings, Adverse reactions | 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Northwind Health Company, LLC | faf7a1ff-f18a-8ca7-e053-6394a90a1b1f | 2026-01-01 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Innogenix, Inc. | 82fc2d64-0572-4a9b-94fc-f6eb8d930c54 | 2025-12-23 | Warnings, Adverse reactions | 896766 896758 896762 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Method Pharmaceuticals, LLC | 733d6e32-ac90-4796-bf25-9d5887c897a5 | 2025-12-23 | Warnings, Adverse reactions | 896766 896758 896762 |
| LABETALOL HYDROCHLORIDE | LABETALOL HYDROCHLORIDE | Redpharm Drug | 32525ed4-3cca-2b99-e063-6294a90a6c66 | 2025-12-13 | Warnings, Adverse reactions | 896758 |
| Labetalol Hydrochloride | LABETALOL HYDROCHLORIDE | Chartwell RX, LLC | ac439c08-1e47-4306-8308-b31d7a1a443c | 2025-12-02 | Warnings, Adverse reactions | 896766 896758 896762 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.